Stock Market News — October 22, 2026 — Evening Update — Last 12 Hours (Pacific Time)

Executive Summary

Thursday's session was defined by a brutal AI-driven selloff that sent the Nasdaq to its worst day since June, as surging AI spending concerns hammered Meta (down 7%+), Moderna cratered 25%+ on a cancer vaccine data leak, and the tech rout spread overnight into Asian markets. The U.S. Treasury simultaneously proposed new restrictions on American investment in Chinese AI and advanced chip sectors, adding a geopolitical layer to an already risk-off tape. Amid the carnage, a handful of earnings bright spots — RingCentral (+15.2%), Roper Technologies (+8.8%), and Lockheed Martin's 850-jet Pentagon deal — offered selective relief.

Sentiment Breakdown

Net Sentiment: Bearish — AI spending anxiety, a broad tech selloff, global equity declines across Europe and Asia, and macro headwinds (Japan CPI, French yields) dominated the session with very few offsetting catalysts.

Top Market-Moving Headlines

🔴 Markets | S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
Market Impact: The Nasdaq posted its worst single-day decline since June as investors dumped high-growth tech on AI financing concerns. The S&P 500 also fell sharply while the Dow barely held flat (+0.02%).

🔴 Tech/AI | Meta shares slide 7%+ as AI spending alarms investors; default insurance hits record
Market Impact: Meta beat on Q3 revenue but the stock sold off hard as investors balked at escalating AI capital expenditure commitments. Default insurance reaching a record is a notable stress signal.

🔴 Biotech | Moderna sheds ~$24 billion as cancer vaccine data leak triggers 'sell-the-news' retreat
Market Impact: Moderna plunged nearly 25% and Merck fell over 3% after what appeared to be an unauthorized early release of Phase 3 melanoma vaccine trial data. The Merck/Moderna mRNA vaccine showed a 42% reduction in melanoma death or recurrence risk — strong data, but the leak and "sell-the-news" dynamic crushed both stocks.

🔴 Semiconductors | Asia stocks fall as AI rout batters South Korea; Samsung drops 3.3%, SK Hynix falls 2.8%
Market Impact: The U.S. tech selloff exported directly into Asian markets overnight, with Samsung at ₩207,500 and SK Hynix at ₩1,189,000 leading declines. The Nikkei 225 broke down to 62,287 in deeply oversold territory.

🔴 Semiconductors | SK Hynix puts Solidigm US IPO on hold after Seoul authorities raise concerns
Market Impact: SK Hynix scrapped plans for a U.S. listing of its Solidigm chip unit, citing market conditions and regulatory pushback from Seoul. This removes a key IPO catalyst and compounds the stock's slide.

🔴 Consumer Tech | Western Digital shares slide ~8% after-hours as cost pressures and higher capex overshadow earnings
Market Impact: Despite a Q1 beat, management's flagging of rising cost pressures and elevated capital expenditure guidance spooked investors, sending shares down sharply in extended trading.

🔴 Consumer/Retail | Deckers Outdoor falls 9.6% after-hours on second-quarter results
Market Impact: Shares dropped nearly 10% in extended trading following the quarterly report; specific earnings details were not fully disclosed but the market reaction signals a meaningful miss or guidance cut.

🔴 Energy/Clean Tech | GE Vernova tumbles 10.9% to $824.90 in broad rotation out of AI-adjacent power plays
Market Impact: GE Vernova was caught in a punishing sector rotation as investors fled AI infrastructure and power-linked names. Parker-Hannifin (-8.1%) and Howmet Aerospace (-7.0%) fell alongside it.

🔴 Geopolitics/Tech | U.S. Treasury proposes rules restricting investment in Chinese AI, advanced chips, and quantum sectors
Market Impact: New proposed regulations would bar U.S. companies and investors from backing Chinese AI, advanced semiconductors, and quantum computing — a significant escalation in tech decoupling with broad implications for cross-border capital flows.

🔴 Automotive | GM cancels deal with new US rare-earth magnet plant
Market Impact: GM's exit from a domestic rare-earth magnet supply agreement undermines U.S. supply chain independence efforts for EV motors and raises questions about the viability of the facility.

🟢 Defense | Lockheed Martin lands Pentagon deal for 850 F-35 jets, lifts annual forecast
Market Impact: Lockheed secured a major multi-jet agreement with the Pentagon and raised its full-year outlook, with Q3 EPS of $7.97 beating the $7.52 estimate. A rare bright spot in an otherwise brutal session.

🟢 Telecom/SaaS | RingCentral surges 15.2% after-hours to $91.50 on strong Q3 results
Market Impact: One of the session's standout earnings winners, with the stock jumping sharply on better-than-expected third-quarter performance.

🟢 Industrials | Roper Technologies surges 8.8% on better-than-expected earnings
Market Impact: Roper delivered a clean beat that drove one of the largest single-day gains among large-cap industrials, bucking the broader selloff.

🟢 AI/Autonomous | OpenAI nears $30 billion funding round at $1.25 trillion valuation
Market Impact: The scale of OpenAI's latest fundraise underscores continued private-market conviction in AI even as public-market AI stocks sell off — a notable divergence worth watching.

🟢 Space/Telecom | SpaceX seeks access to 80,000 US cell sites to build nationwide wireless network
Market Impact: SpaceX's push into terrestrial wireless infrastructure represents a major competitive threat to existing carriers and a significant expansion of its addressable market.

🟡 M&A/EV | SpaceX discloses Tesla merger would require Musk's approval; political baggage clouds deal prospects
Market Impact: SpaceX formally acknowledged the merger governance structure while analysts flagged Musk's political profile as a complicating factor. Deal uncertainty remains elevated.

🟡 Trade/Diplomacy | Trump touts $270 million Bombardier investment in the US after threatening sales ban
Market Impact: The announcement follows a classic Trump negotiating pattern — threat followed by deal — and signals continued pressure on foreign companies to commit U.S. capital.

🟢 Pharma/M&A | Gilead acquires PepStar's inflammation drug program for $1.28 billion
Market Impact: Gilead continues to deploy capital into pipeline expansion; the deal adds an oral inflammation asset and signals confidence in the inflammation therapeutic space.

🟡 IPO | Anthropic IPO set to generate massive gains for early backers
Market Impact: Anthropic's imminent public listing is expected to deliver outsized returns to early investors, adding to the AI IPO pipeline narrative even as public AI valuations wobble.

🔴 BNPL/Fintech | Australia's Zip Co plummets 50% to A$1.02 after fraud incident hits Q1 growth
Market Impact: An external fraud incident materially damaged Zip's first-quarter results, triggering a historic single-day collapse and raising broader concerns about BNPL sector fraud risk controls.

Tickers in Focus

Market Implications

The AI spending debate has moved from background noise to the dominant market risk. Meta's selloff despite a revenue beat, Lam Research falling ~10% on record results, and the Nasdaq's worst day since June all point to a market that is no longer willing to give AI-heavy capex spenders the benefit of the doubt. The question heading into next week is whether this is a healthy valuation reset or the beginning of a more sustained de-rating of the AI trade — and earnings from remaining mega-caps will be the key test.

The U.S.-China tech decoupling is accelerating on multiple fronts simultaneously: Treasury's proposed investment restrictions on Chinese AI and advanced chips, the FCC blocking Chinese surveillance chip devices, and GM's cancellation of its rare-earth magnet deal all landed in the same 12-hour window. This isn't coincidence — it reflects a coordinated policy posture that will force supply chain and capital allocation decisions across the semiconductor, EV, and defense sectors for years to come.

Sector rotation is clearly underway. Consumer staples (PepsiCo +2.5%, P&G beat), defense (Lockheed's F-35 deal), and select SaaS names (RingCentral +15.2%) are absorbing flows fleeing AI-adjacent tech, clean energy, and semiconductor names. With PMI data and consumer sentiment due Friday, the macro backdrop could either validate the rotation into defensives or provide a relief catalyst for beaten-down growth names. Gold miners face a mixed setup — Newmont beat but the sector broadly faces margin pressure from lower gold prices and elevated costs.

Key Takeaways

• Nasdaq — Worst day since June; AI financing fears are now the market's primary near-term risk driver.
• META — Beat on revenue but investors are punishing AI capex commitments; default insurance hitting a record is a serious warning signal.
• MRNA — A 25% single-day collapse on a data leak is extraordinary; the mRNA cancer vaccine data was actually strong (42% melanoma risk reduction), making this a pure "sell-the-news" and leak-driven event.
• MRK — Collateral damage from the Moderna data leak despite being a co-developer of the vaccine showing positive results.
• WDC — Earnings beat matters less than forward cost guidance; the ~8% after-hours drop shows the market is hyper-focused on margin trajectories.
• SK Hynix / Samsung — The U.S. AI rout is directly transmitting into Korean chip stocks; SK Hynix scrapping the Solidigm IPO removes a near-term catalyst.
• ZIP.ASX — A 50% single-day crash from a fraud incident is a stark reminder of operational risk in BNPL; sector-wide scrutiny likely follows.
• LMT — The 850 F-35 Pentagon deal and raised guidance make Lockheed one of the cleanest earnings stories of the week; defense remains a relative safe haven.
• RNG — A 15.2% after-hours surge signals the market is still willing to reward SaaS names that deliver; watch for follow-through Friday.
• GILD — The $1.28B PepStar acquisition continues Gilead's pipeline-building strategy in inflammation; a quiet but meaningful deal.
• SpaceX/TSLA — The merger governance disclosure (requires Musk approval) and political baggage analysis suggest this deal faces significant structural and reputational headwinds.
• SpaceX wireless — Seeking 80,000 cell sites for a nationwide network is a direct competitive threat to AT&T, Verizon, and T-Mobile; watch telecom sector reaction.
• U.S.-China tech restrictions — Treasury's proposed investment curbs on Chinese AI, chips, and quantum are a major policy escalation; U.S. VC and PE firms with China exposure face compliance overhaul.
• GM rare-earth — Canceling the domestic magnet plant deal undermines the U.S. EV supply chain independence narrative and raises questions about GM's EV cost strategy.
• OpenAI — A $30B raise at a $1.25 trillion valuation in private markets while public AI stocks sell off creates a striking divergence; private AI valuations may be the next shoe to drop.
• Anthropic IPO — Imminent listing expected to deliver massive early-backer gains; timing into a volatile AI tape will be closely watched.
• Sector rotation — Consumer staples, defense, and select SaaS are the clear beneficiaries of the AI/tech exodus; this rotation has legs if AI capex concerns persist.
• Bombardier — The $270M U.S. investment commitment following Trump's sales ban threat follows a now-familiar pattern; trade policy as negotiating leverage remains active.
• Pony.ai + Nvidia + inDrive — Robotaxi expansion into Kazakhstan is a small but notable signal of autonomous vehicle deployment moving beyond China and the U.S.
• Rio Tinto — A $1.9B commitment to Queensland bauxite signals continued confidence in long-cycle materials demand despite near-term market volatility.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Insider transactions can have many motivations beyond stock outlook.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/